Browse > Article
http://dx.doi.org/10.4014/jmb.1604.04053

Validation of Analytical Methods for Plasma Total Antioxidant Capacity by Comparing with Urinary 8-Isoprostane Level  

Lee, Sang Gil (Department of Nutritional Sciences, University of Connecticut)
Wang, Taoran (Department of Nutritional Sciences, University of Connecticut)
Vance, Terrence M. (Department of Nutritional Sciences, University of Connecticut)
Hurbert, Patrice (Department of Nutritional Sciences, University of Connecticut)
Kim, Dae-Ok (Department of Food Science and Biotechnology, Kyung Hee University)
Koo, Sung I. (Department of Nutritional Sciences, University of Connecticut)
Chun, Ock K. (Department of Nutritional Sciences, University of Connecticut)
Publication Information
Journal of Microbiology and Biotechnology / v.27, no.2, 2017 , pp. 388-394 More about this Journal
Abstract
Although several analytical methods for measuring total antioxidant capacity (TAC) have been applied to biological samples, there were often dissimilar results due to the different principles of methods applied. Thus, this study aimed to validate four conventional analytical methods for measuring plasma TAC, including the ABTS assay, DPPH assay, FRAP assay, and ORAC assay, by comparing with urinary 8-isoprostane concentration. In addition, TAC results were compared with antioxidant enzyme activities including superoxide dismutase (SOD) and glutathione peroxidase in erythrocyte, and catalase in plasma. Plasma TAC measure by ABTS assay was strongly correlated with the result by FRAP assay. Plasma TAC by FRAP and ORAC assays were negatively correlated with erythrocyte SOD activity. The agreement among the four TAC assay methods and 8-isoprostane was determined using 95% prediction limits of linear regression, expressed as the mean of 8-isoprostane ${\pm}95%$ prediction limits. The ABTS method better agreed with 8-isoprostane than the other methods, demonstrating narrow prediction of limits. Furthermore, only plasma TAC determined by the ABTS assay was inversely correlated with urinary 8-isoprostane (r = -0.35, p < 0.05). In summary, the ABTS assay would be an appropriate method to measure overall plasma antioxidant capacity and predict the body's antioxidant status.
Keywords
Total antioxidant capacity; ABTS assay; FRAP assay; 8-isoprostane; superoxide dismutase;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sarban S, Kocyigit A, Yazar M, Isikan UE. 2005. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin. Biochem. 38: 981-986.   DOI
2 Janaszewska A, Bartosz G. 2002. Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand. J. Clin. Lab. Invest. 62: 231-236.   DOI
3 Montuschi P, Barnes PJ, Roberts LJ 2nd. 2004. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 18: 1791-1800.   DOI
4 Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84: 407-412.   DOI
5 Wang Y, Yang M, Lee SG, Davis CG, Kenny A, Koo SI, Chun OK. 2012. Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women. J. Nutr. Biochem. 23: 1725-1731.   DOI
6 Bland JM, Altman DG. 2003. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet. Gynecol. 22: 85-93.
7 Altman DG, Bland JM. 1983. Measurement in medicine: the analysis of method comparison studies. Statistician 32: 307-317.   DOI
8 Jansen EH, Ruskovska T. 2013. Comparative analysis of serum (anti)oxidative status parameters in healthy persons. Int. J. Mol. Sci. 14: 6106-6115.   DOI
9 Wang Y, Yang M, Lee SG, Davis CG, Koo SI, Chun OK. 2012. Dietary total antioxidant capacity is associated with diet and plasma antioxidant status in healthy young adults. J. Acad. Nutr. Diet. 112: 1626-1635.   DOI
10 Maples KR, Mason RP. 1988. Free radical metabolite of uric acid. J. Biol. Chem. 263: 1709-1712.
11 Cao G, Prior RL. 1998. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. Chem. 44: 1309-1315.
12 Ames BN, Cathcart R, Schwiers E, Hochstein P. 1981. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA 78: 6858-6862.   DOI
13 Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. 1987. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta 924: 408-419.   DOI
14 Marques SS, Magalhaes LM, Toth IV, Segundo MA. 2014. Insights on antioxidant assays for biological samples based on the reduction of copper complexes - the importance of analytical conditions. Int. J. Mol. Sci. 15: 11387-11402.   DOI
15 Morita A, Minami H, Sakakibara N, Sato K, Tsuji T. 1996. Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J. Dermatol. Sci. 11: 196-201.   DOI
16 Ishikawa M, Yaginuma Y, Hayashi H, Shimizu T, Endo Y, Taniguchi N. 1990. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res. 50: 2538-2542.
17 Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM. 2006. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic. Biol. Med. 40: 341-347.   DOI
18 Jackson R, Ramos C, Gupta C, Gomez-Marin O. 2010. Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients. Respir. Med. 104: 1919-1928.   DOI
19 Wang CC, Chu CY, Chu KO, Choy KW, Khaw KS, Rogers MS, Pang CP. 2004. Trolox-equivalent antioxidant capacity assay versus oxygen radical absorbance capacity assay in plasma. Clin. Chem. 50: 952-954.   DOI
20 Thompson HJ, Heimendinger J, Sedlacek S, Haegele A, Diker A, O'Neill C, et al. 2005. 8-Isoprostane F2alpha excretion is reduced in women by increased vegetable and fruit intake. Am. J. Clin. Nutr. 82: 768-776.   DOI
21 Queiros RB, Tafulo PA, Sales MG. 2013. Assessing and comparing the total antioxidant capacity of commercial beverages: application to beers, wines, waters and soft drinks using TRAP, TEAC and FRAP methods. Comb. Chem. High Throughput Screen. 16: 22-31.   DOI
22 Khan SR. 2012. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol. Res. 40: 95-112.   DOI
23 Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA, Bozner P. 1998. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152: 871-877.
24 Font R, Prats M, Gutierrez C, Bardaji A, Lalana M, Marsillach J, et al. 2009. Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease? Nefrologia 29: 228-235.
25 Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bachler JP. 2007. Relationship between oxidative stress and essential hypertension. Hypertens. Res. 30: 1159-1167.   DOI
26 Prior RL, Cao G. 1999. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic. Biol. Med. 27: 1173-1181.   DOI
27 Rodriguez-Sureda V, Vilches A, Sanchez O, Audi L, Dominguez C. 2015. Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid. Med. Cell. Longev. 2015: 509241.
28 Yeum KJ, Russell RM, Krinsky NI, Aldini G. 2004. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch. Biochem. Biophys. 430: 97-103.   DOI
29 Tai P, Ascoli M. 2011. Reactive oxygen species (ROS) play a critical role in the cAMP-induced activation of Ras and the phosphorylation of ERK1/2 in Leydig cells. Mol. Endocrinol. 25: 885-893.   DOI
30 Tickner J, Fan LM, Du J, Meijles D, Li JM. 2011. Nox2- derived ROS in PPARgamma signaling and cell-cycle progression of lung alveolar epithelial cells. Free Radic. Biol. Med. 51: 763-772.   DOI
31 Subramaniam R, Barnes PF, Fletcher K, Boggaram V, Hillberry Z, Neuenschwander P, Shams H. 2014. Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production. J. Infect. Dis. 209: 1827-1836.   DOI
32 Schieber M, Chandel NS. 2014. ROS function in redox signaling and oxidative stress. Curr. Biol. 24: 453-462.   DOI